Efficacy News and Research

RSS
Two studies uncover limitations in screening for hepatocellular carcinoma

Two studies uncover limitations in screening for hepatocellular carcinoma

Positive interim data from Anthera's PEARL-SC phase 2b clinical study in systemic lupus erythematosus

Positive interim data from Anthera's PEARL-SC phase 2b clinical study in systemic lupus erythematosus

Enrollment complete in Ceregene's CERE-120 Phase 2b trial for Parkinson's

Enrollment complete in Ceregene's CERE-120 Phase 2b trial for Parkinson's

Auxilium initiates XIAFLEX phase IIa trial in Frozen Shoulder syndrome

Auxilium initiates XIAFLEX phase IIa trial in Frozen Shoulder syndrome

Conference to explore acute ischemic stroke treatment

Conference to explore acute ischemic stroke treatment

Statens Serum Institut, Aeras initiate new candidate TB vaccine Phase I trial

Statens Serum Institut, Aeras initiate new candidate TB vaccine Phase I trial

Duplex ultrasound screening can detect high rate of LDVT's in critically ill trauma patients

Duplex ultrasound screening can detect high rate of LDVT's in critically ill trauma patients

Genentech announces results from pertuzumab studies on HER2-positive breast cancer

Genentech announces results from pertuzumab studies on HER2-positive breast cancer

Polarized filter may improve ability to detect precancerous changes, reduce unnecessary biopsies

Polarized filter may improve ability to detect precancerous changes, reduce unnecessary biopsies

Study examines alternative immunization schedule occurrence rates in Washington State

Study examines alternative immunization schedule occurrence rates in Washington State

Scientists create genetically-altered neurons that light up as they fire

Scientists create genetically-altered neurons that light up as they fire

FDA assigns priority-review designation for ELIQUIS NDA for stroke prevention in atrial fibrillation

FDA assigns priority-review designation for ELIQUIS NDA for stroke prevention in atrial fibrillation

BioLineRx reports third quarter net loss of NIS 7.9 million

BioLineRx reports third quarter net loss of NIS 7.9 million

Pediatricians frequently asked to provide alternative childhood vaccine schedules

Pediatricians frequently asked to provide alternative childhood vaccine schedules

Critical breakthrough in development of treatment for Duchenne Muscular Dystrophy

Critical breakthrough in development of treatment for Duchenne Muscular Dystrophy

VOICE continues testing daily use of ARV Truvada among women in sub-Saharan Africa

VOICE continues testing daily use of ARV Truvada among women in sub-Saharan Africa

FDA grants IND for AEZS-130 Phase 2A trial in cancer cachexia

FDA grants IND for AEZS-130 Phase 2A trial in cancer cachexia

Inviragen commences DENVax Phase 2 trial for dengue

Inviragen commences DENVax Phase 2 trial for dengue

Inspiration commences enrollment in second OBI-1 Accur8 clinical trial program for congenital hemophilia A

Inspiration commences enrollment in second OBI-1 Accur8 clinical trial program for congenital hemophilia A

Bayer, Regeneron commence EYLEA Phase 3 clinical trial for wet AMD in China

Bayer, Regeneron commence EYLEA Phase 3 clinical trial for wet AMD in China

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.